Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Exscientia Plc - American Depositary Shares

< Previous 1 2 3 4 5 Next >

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture

December 01, 2025

Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...

Via TokenRing AI

Topics Artificial Intelligence Economy Emissions

AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare

October 22, 2025

The pharmaceutical and biotechnology industries are undergoing a profound transformation, driven by an urgent need for more efficient drug discovery and development processes and the paradigm shift...

Via TokenRing AI

Topics Animal Testing Artificial Intelligence

Healthcare’s AI Revolution: Generative Intelligence Delivers Real Returns as Agentic Systems Drive Measurable Outcomes

October 17, 2025

The healthcare industry is experiencing a profound transformation, propelled by the accelerating adoption of artificial intelligence. While AI's potential has long been discussed, recent advancements...

Via TokenRing AI

Topics Artificial Intelligence Economy

AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market

October 14, 2025

The pharmaceutical industry stands on the precipice of a revolutionary transformation, driven by the burgeoning power of artificial intelligence (AI) agents. These sophisticated, autonomous systems are...

Via TokenRing AI

Topics Artificial Intelligence Intellectual Property

AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants

October 01, 2025

As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...

Via MarketMinute

Topics Artificial Intelligence

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

The Dawn of Hyper-Personalization: How Generative AI is Reshaping Our Digital World

August 04, 2025

The digital landscape is undergoing a profound transformation as personalized AI, particularly generative AI models, are increasingly being fine-tuned to individual preferences and histories. This...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

NVIDIA Invested in These 2 AI Stocks, Should You?

December 02, 2024

Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.

Via MarketBeat

Topics Artificial Intelligence

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 08, 2024

Via Benzinga

AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week ↗

September 15, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual...

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th ↗

September 10, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 and should result in as many as 50 novel therapies being brought to market by then and generate annual...

Via Talk Markets

Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! ↗

September 05, 2024

The August ISM manufacturing index reported on Tuesday that figures came in below consensus expectation. That raised fears about the strength of the economy, driving down our Our AI-Focused Drug...

Via Talk Markets

Topics Economy

Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week ↗

August 27, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030.

Via Talk Markets

The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. ↗

August 18, 2024

Merging with a former rival will bolster its capabilities.

Via The Motley Fool

EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q2 2024 ↗

August 15, 2024

EXAI stock results show that Exscientia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD ↗

August 14, 2024

The AI-powered drug discovery process is expected to grow by a 30% CAGR between now and 2030 which should result in approximately 50 novel therapies and generate annual sales in excess of $50 billion...

Via Talk Markets

Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia? ↗

August 11, 2024

The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger.

Via The Motley Fool

Topics Artificial Intelligence

AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals ↗

August 08, 2024

Exscientia merges with Recursion Pharmaceuticals in an all-stock deal. The new entity, named Recursion, will focus on industrializing drug discovery with advanced AI technologies, boasting $850 million...

Via Benzinga

Topics Artificial Intelligence

AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD ↗

July 30, 2024

The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030.

Via Talk Markets

AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD ↗

July 18, 2024

To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under...

Via Talk Markets

Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD ↗

July 14, 2024

The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,...

Via Talk Markets

3 Small-Cap Stocks With Explosive 2X Growth Potential ↗

July 08, 2024

Discover three top high-growth small-cap stocks, fueled by potential rate cuts and promising prospects in the second half of 2024.

Via InvestorPlace

Clinical-Stage BioTech Drug Stocks Declined 13% In June ↗

July 01, 2024

Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read

Via Talk Markets

Largest Clinical-Stage BioTech Drug Stocks Declined 6% ↗

June 22, 2024

Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th ↗

June 17, 2024

The global

Via Talk Markets

AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week ↗

June 10, 2024

The global

Via Talk Markets

The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May ↗

June 01, 2024

The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May.

Via Talk Markets

Topics Artificial Intelligence

7 Underappreciated Stocks With 25% Return Potential in 2024 ↗

May 30, 2024

Each of these underappreciated stocks is expected to provide 25%+ returns this year, which is reason enough to pay attention.

Via InvestorPlace

The 3 Best Machine Learning Stocks to Quadruple Your Money by 2035 ↗

May 23, 2024

One of the hottest investment trends to jump on at the moment is machine learning stocks to buy. Here are three.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.